Tauroursodeoxycholic acid binds to the G-protein site on light activated rhodopsin.

Tauroursodeoxycholic acid binds to the G-protein site on light activated rhodopsin.
复制标题

DOI:
10.1016/j.exer.2018.02.015
复制
发表时间:
2018-05
影响因子:
3.4
通讯作者:
Kisselev OG
Kisselev OG
中科院分区:
医学3区
文献类型:
--
作者:
Lobysheva E;Taylor CM;Marshall GR;Kisselev OG

文献摘要

参考文献

被引文献

相似文献

G 蛋白偶联受体上的异三聚体 G 蛋白结合位点作为治疗干预的新靶点或作为现有药物的次要作用位点的潜力仍然相对未经探索。牛磺熊去氧胆酸与先前已鉴定的几种化合物具有结构相似性,这些化合物特异性结合视觉受体视紫红质的光激活形式并抑制其转导蛋白的激活。我们发现 TUDCA 可以稳定视紫红质的活性形式,即变视紫红质 II,并且不会表现出具有胆固醇支架结构的常见两亲化合物(例如脱氧胆酸)的类似洗涤剂的作用。 TUDCA 与光激活视紫红质模型的计算机对接表明,它通过与转导蛋白 α 亚基 C 端结构域的类似结合模式进行相互作用。 TUDCA 的环区域与视紫红质的环 3 区域进行疏水接触,而 TUDCA 的尾部暴露于溶剂。结果表明,TUDCA 与视紫红质特异性相互作用,这可能有助于其对视网膜生理学产生广泛的影响,并作为视网膜退行性疾病的潜在治疗化合物。
The heterotrimeric G-protein binding site on G-protein coupled receptors remains relatively unexplored regarding its potential as a new target of therapeutic intervention or as a secondary site of action by the existing drugs. Tauroursodeoxycholic acid bears structural resemblance to several compounds that were previously identified to specifically bind to the light-activated form of the visual receptor rhodopsin and to inhibit its activation of transducin. We show that TUDCA stabilizes the active form of rhodopsin, metarhodopsin II, and does not display the detergent-like effects of common amphiphilic compounds that share the cholesterol scaffold structure, such as deoxycholic acid. Computer docking of TUDCA to the model of light-activated rhodopsin revealed that it interacts using similar mode of binding to the C-terminal domain of transducin alpha subunit. The ring regions of TUDCA made hydrophobic contacts with loop 3 region of rhodopsin, while the tail of TUDCA is exposed to solvent. The results show that TUDCA interacts specifically with rhodopsin, which may contribute to its wide-ranging effects on retina physiology and as a potential therapeutic compound for retina degenerative diseases.
蛋白质动力学在GPCR功能中的作用:β2AR和视紫红质的见解。
DOI: 10.1016/j.ceb.2014.01.008
发表时间: 2014-04
影响因子: 7.5
作者:
Manglik, Aashish;Kobilka, Brian
通讯作者: Kobilka, Brian
DOI: 10.1016/b978-0-12-417197-8.00001-8
发表时间: 2014
期刊: Advances in pharmacology (San Diego, Calif.)
影响因子: --
作者:
Park, Paul Shin-Hyun
通讯作者: Park, Paul Shin-Hyun
DOI: 10.1021/bi00708a031
发表时间: 1974-01-01
期刊: BIOCHEMISTRY
影响因子: 2.9
作者:
PAPERMASTER, DS;DREYER, WJ
通讯作者: DREYER, WJ
DOI: 10.1038/nature09789
发表时间: 2011-03-31
期刊: NATURE
影响因子: 64.8
作者:
Choe, Hui-Woog;Kim, Yong Ju;Ernst, Oliver P.
通讯作者: Ernst, Oliver P.
DOI: 10.1007/978-1-4614-3209-8_99
发表时间: 2014-01-01
期刊: RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY
影响因子: --
作者:
Fu, Yingbin;Zhang, Tao
通讯作者: Zhang, Tao